【结 构 式】 |
【药物名称】Tipranavir, PNU-140690E(diNa salt), PNU-140690, U-140690 【化学名称】N-[3-[1(R)-[4-Hydroxy-2-oxo-6(R)-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide 【CA登记号】174484-41-4, 191150-83-1 (diNa salt) 【 分 子 式 】C31H33F3N2O5S 【 分 子 量 】602.67826 |
【开发单位】Pfizer (Originator), Boehringer Ingelheim (Licensee) 【药理作用】AIDS Medicines, Anti-HIV Agents, ANTIINFECTIVE THERAPY, HIV Protease Inhibitors |
合成路线1
The condensation of 4(R)-phenyloxazolidin-2-one (I) with 2(E)-pentenoyl chloride (II) by means of BuLi in THF gives 3-[2(E)-pentenoyl]-3(R)-phenyloxazolidin-2-one (III), which is treated with 3-[bis(trimethylsilyl)amino]phenylmagnesium bromide (IV) and CuBr in DMSO/THF regioselectively yielding the addition product (V). Elimination of the silyl groups of (VII) in mild acidic conditions and treatment of the resulting amine with benzyl bromide affords the dibenzylated amine derivative (VI), which is regioselectively acylated with 2-methoxy-2-methyl-1,3-dioxolane (V) and TiCl4 in dichloromethane under basic conditions giving the dione (VIII). The condensation of (VIII) with 1-phenyl-3-hexanone (IX) by means of Ti(OBu)Cl3 in dichloromethane as before yields the hydroxy-dione (X), which is cyclized by means of potassium tert-butoxide in THF to afford the dihydropyrone (XI). The debenzylation of (XI) by hydrogenation with H2 over Pd/C in methanol/ethyl acetate gives the free amine (XII), which is finally sulfonated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride (XIII) in pyridine/dichloromethane
【1】 Graul, J.; Wroblewski, T.; Castañer, J.; PNU-140690. Drugs Fut 1998, 23, 2, 146. |
【2】 Romines, K.R.; Bundy, G.L.; Schwartz, T.M.; Tommasi, R.A.; Strohbach, J.W.; Turner, S.R.; Thaisrivongs, S.; Aristoff, P.A.; Johnson, P.D.; Skulnick, H.I.; Skaletzki, L.L.; Anderson, D.J.; Morris, J.; Gammill, R.B.; Luke, G.P. (Pharmacia Corp.); Pyranone cpds. useful to treat retroviral infections. EP 0758327; JP 1997512821; US 5852195; WO 9530670 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 12173 | (4S)-4-Phenyl-1,3-oxazolan-2-one; (4S)-4-Phenyl-2-oxazolidinone; (S)-(+)-4-Phenyl-2-oxazolidinone | 99395-88-7 | C9H9NO2 | 详情 | 详情 |
(II) | 17226 | (E)-2-pentenoyl chloride | C5H7ClO | 详情 | 详情 | |
(III) | 17227 | (4R)-3-[(E)-2-pentenoyl]-4-phenyl-1,3-oxazolan-2-one | C14H15NO3 | 详情 | 详情 | |
(IV) | 17228 | N-(3-methylphenyl)-N,N-bis(trimethylsilyl)amine; trimethyl-N-(3-methylphenyl)-N-(trimethylsilyl)silanamine | C13H25NSi2 | 详情 | 详情 | |
(V) | 17229 | (4R)-3-((3S)-3-[3-[bis(trimethylsilyl)amino]phenyl]pentanoyl)-4-phenyl-1,3-oxazolan-2-one | C26H38N2O3Si2 | 详情 | 详情 | |
(VI) | 17230 | (4R)-3-[(3S)-3-[3-(dibenzylamino)phenyl]pentanoyl]-4-phenyl-1,3-oxazolidin-2-one | C34H34N2O3 | 详情 | 详情 | |
(VII) | 17231 | 2-methoxy-2-methyl-1,3-dioxolane; methyl 2-methyl-1,3-dioxolan-2-yl ether | C5H10O3 | 详情 | 详情 | |
(VIII) | 17232 | (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione | C36H36N2O4 | 详情 | 详情 | |
(IX) | 17233 | 1-phenyl-3-hexanone | C12H16O | 详情 | 详情 | |
(X) | 17234 | (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-1,3-octanedione | C48H52N2O5 | 详情 | 详情 | |
(XI) | 17235 | (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C39H43NO3 | 详情 | 详情 | |
(XII) | 17236 | (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H31NO3 | 详情 | 详情 | |
(XIII) | 17237 | 5-(trifluoromethyl)-2-pyridinesulfonyl chloride | C6H3ClF3NO2S | 详情 | 详情 |
合成路线2
2) The previously obtained dione (VIII) can also be condensed with 1-phenyl-4-pentyn-1-one (XIV) by means of Ti(OBu)Cl3 in dichloromethane as before yielding the unsaturated hydroxy-dione (XV), which is cyclized by means of potassium tert-butoxide in THF to afford the dihydropyrone (XVI). The hydrogenation of the triple bond of (XVI) with simultaneous debenzylation by means of H2 over Pd/C in methanol/ethyl acetate gives the previously obtained free amine derivative (XII).
【1】 Graul, J.; Wroblewski, T.; Castañer, J.; PNU-140690. Drugs Fut 1998, 23, 2, 146. |
【2】 Morris, J.K.; Phillips, G.; Judge, T.M.; et al.; Asymmetric syntheses and absolute stereochemistry of 5,6-dihydro-alpha-pyrones, a new class of potent HIV protease inhibitors. J Am Chem Soc 1997, 119, 15, 3627-8. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIII) | 17232 | (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione | C36H36N2O4 | 详情 | 详情 | |
(XII) | 17236 | (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H31NO3 | 详情 | 详情 | |
(XIV) | 17238 | 1-phenyl-4-hexyn-3-one | C12H12O | 详情 | 详情 | |
(XV) | 17239 | (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-6-octyne-1,3-dione | C48H48N2O5 | 详情 | 详情 | |
(XVI) | 17240 | (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-(1-propynyl)-5,6-dihydro-2H-pyran-2-one | C39H39NO3 | 详情 | 详情 |
合成路线3
1) The condensation of 1-phenylhexan-3-one (I) with ethyl acetate by means of butyllithium and diisopropylamine in THF gives racemic 3-hydroxy-3-(2-phenylethyl)hexanoic acid ethyl ester (II), which is hydrolyzed with NaOH in methanol to the corresponding free acid (III). The optical resolution of (III) with (1R,2S)-(-)-norephedrine (IV) followed by treatment with aqueous HCl yields the chiral (R)-acid (V), which is treated with 4-biphenylyloxymethyl chloride (VI) and diisopropylethylamine in toluene affording the protected ester (VII). The reduction of the ester group of (VII) with diisobutylaluminum hydride (DIBAL) in toluene gives the monoprotected diol (VIII), which is oxidized at the primary hydroxy group with 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy radical (TEMPO) and NaOCl yielding the corresponding aldehyde (IX). The condensation of (IX) with (R)-3-(3-nitrophenyl)pentanoic acid methyl ester (X) by means of sodium hexamethyldisilazide (NaHMDS) in THF gives the hydroxyester (XI) as a mixture of four diastereomers. This mixture is oxidized with pyridinium chlorochromate (PCC) in dichloromethane to afford the ketoester (XII) also as a mixture of two diastereomers. Elimination of the biphenylyloxymethyl protecting group with H2SO4 in methanol yields the hydroxy ketoester (XIII).
【1】 Fors, K.S.; et al.; A convergent, scalable synthesis of HIV protease inhibitor PNU-140690. J Org Chem 1998, 63, 21, 7348. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
17491 | ethyl acetate | 141-78-6 | C4H8O2 | 详情 | 详情 | |
(I) | 17233 | 1-phenyl-3-hexanone | C12H16O | 详情 | 详情 | |
(II) | 21156 | ethyl 3-hydroxy-3-phenethylhexanoate | C16H24O3 | 详情 | 详情 | |
(III) | 21157 | 3-hydroxy-3-phenethylhexanoic acid | C14H20O3 | 详情 | 详情 | |
(IV) | 13355 | 2-Amino-1-phenyl-1-propanol; (1S,2R)-(+)-Norephedrine | 37577-28-9 | C9H13NO | 详情 | 详情 |
(IV) | 21158 | (1R,2S)-2-amino-1-phenyl-1-propanol | C9H13NO | 详情 | 详情 | |
(V) | 21159 | (3R)-3-hydroxy-3-phenethylhexanoic acid | C14H20O3 | 详情 | 详情 | |
(VI) | 21160 | [1,1'-biphenyl]-4-yl chloromethyl ether; 4-(chloromethoxy)-1,1'-biphenyl | C13H11ClO | 详情 | 详情 | |
(VII) | 21161 | ([1,1'-biphenyl]-4-yloxy)methyl (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethylhexanoate | C40H40O5 | 详情 | 详情 | |
(VIII) | 21162 | (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethyl-1-hexanol | C27H32O3 | 详情 | 详情 | |
(IX) | 21163 | (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethylhexanal | C27H30O3 | 详情 | 详情 | |
(X) | 21164 | methyl (3S)-3-(3-nitrophenyl)pentanoate | C12H15NO4 | 详情 | 详情 | |
(XI) | 21165 | methyl (5R)-5-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-5-phenethyloctanoate | C39H45NO7 | 详情 | 详情 | |
(XII) | 21166 | methyl (5R)-5-[([1,1'-biphenyl]-4-yloxy)methoxy]-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate | C39H43NO7 | 详情 | 详情 | |
(XIII) | 21167 | methyl (5R)-5-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate | C26H33NO6 | 详情 | 详情 |
合成路线4
The hydroxy ketoester (XIII) (Scheme 24009402a), which is cyclized by means of NaOH in methanol/water affording the dihydropyranone (XIV). The reduction of the nitro group of (XIV) with hydrogen over Pd/C in THF gives the corresponding aniline (XV), which is finally amidated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride and pyridine in DMSO.
【1】 Fors, K.S.; et al.; A convergent, scalable synthesis of HIV protease inhibitor PNU-140690. J Org Chem 1998, 63, 21, 7348. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XIII) | 21167 | methyl (5R)-5-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate | C26H33NO6 | 详情 | 详情 | |
(XIV) | 21168 | (6R)-4-hydroxy-3-[(1R)-1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H29NO5 | 详情 | 详情 | |
(XV) | 17236 | (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H31NO3 | 详情 | 详情 | |
(XVI) | 17237 | 5-(trifluoromethyl)-2-pyridinesulfonyl chloride | C6H3ClF3NO2S | 详情 | 详情 |
合成路线5
2) The chiral intermediate (X) has been obtained by two different ways: a) The Knovenagel condensation of dimethyl malonate (XVII) with 3-nitrobenzaldehyde (XVIII) gives the corresponding benzylidenemalonate (XIX), which is alkylated with diethyl zinc and CuBr in DMSO yielding 2-[1-(3-nitrophenyl)propyl]malonic acid dimethyl ester (XX). The partial decarboxylation of (XX) with 6N HCl affords racemic 3-(3-nitrophenyl)pentanoic acid (XXI), which is esterified with methanol/HCl to the racemic methyl ester (XXII). Finally, this racemate is resolved by chromatography over a chiral (R,R)Whelk-O1 column giving the desired intermediate (X). b) The regioselective acetylation of 1-(3-nitrophenyl)-1-propanol (XXIII) with isopropenyl acetate (XXIV) catalyzed by Amano P30 lipase gives a mixture of the (S)-acetate (XXV) and unreacted (R)-alcohol (XXVI). After separation, (XXVI) was mesylated with mesyl chloride as usual yielding mesylate (XXVII), which was condensed with the sodium salt of diethyl malonate (XXVIII) affording the chiral malonic ester (XXIX). Partial decarboxylation of (XXIX) with 6N HCl gives the chiral pentanoic acid (XXX), which is finally esterified to the desired intermediate (X) with methanol/HCl.
【1】 Fors, K.S.; et al.; A convergent, scalable synthesis of HIV protease inhibitor PNU-140690. J Org Chem 1998, 63, 21, 7348. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 21164 | methyl (3S)-3-(3-nitrophenyl)pentanoate | C12H15NO4 | 详情 | 详情 | |
(XVII) | 19373 | dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester | 108-59-8 | C5H8O4 | 详情 | 详情 |
(XVIII) | 12646 | 3-Nitrobenzaldehyde | 99-61-6 | C7H5NO3 | 详情 | 详情 |
(XIX) | 21173 | dimethyl 2-(3-nitrobenzylidene)malonate | C12H11NO6 | 详情 | 详情 | |
(XX) | 21174 | dimethyl 2-[1-(3-nitrophenyl)propyl]malonate | C14H17NO6 | 详情 | 详情 | |
(XXI) | 21175 | 3-(3-nitrophenyl)pentanoic acid | C11H13NO4 | 详情 | 详情 | |
(XXII) | 21176 | methyl 3-(3-nitrophenyl)pentanoate | C12H15NO4 | 详情 | 详情 | |
(XXIII) | 21177 | 1-(3-nitrophenyl)-1-propanol | C9H11NO3 | 详情 | 详情 | |
(XXIV) | 21178 | isopropenyl acetate | 108-22-5 | C5H8O2 | 详情 | 详情 |
(XXV) | 21179 | (1S)-1-(3-nitrophenyl)propyl acetate | C11H13NO4 | 详情 | 详情 | |
(XXVI) | 21180 | (1R)-1-(3-nitrophenyl)-1-propanol | C9H11NO3 | 详情 | 详情 | |
(XXVII) | 21181 | (1R)-1-(3-nitrophenyl)propyl methanesulfonate | C10H13NO5S | 详情 | 详情 | |
(XXVIII) | 21182 | Diethyl malonate sodium salt | C7H11NaO4 | 详情 | 详情 | |
(XXIX) | 21183 | diethyl 2-[(1S)-1-(3-nitrophenyl)propyl]malonate | C16H21NO6 | 详情 | 详情 | |
(XXX) | 21184 | (3S)-3-(3-nitrophenyl)pentanoic acid | C11H13NO4 | 详情 | 详情 |
合成路线6
A new synthesis of PNU-140690 has been developed: The condensation of 1-phenyl-3-hexanone (I) with methyl acetoacetate (II) by means of NaH in THF, followed by cyclization gives the hydroxypyrone (III), which by condensation with 3-nitrobenzaldehyde (IV) by means of AlCl3 in THF yields the benzylidene-pyrone (V). The alkylation of (V) with Et3Al, CuBr-Me2S in THF affords intermediate (VI), which is reduced at the nitro group with H2 over Pd/C in methanol giving the racemic amine (VII). The optical resolution of the N-benzyloxycarbonyl derivative of (VII) with chiral HPLC yielded the desired (R,R)-enantiomer (VIII), which was finally sulfonated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride (IX) in pyridine/dichloromethane.
【1】 Turner, S.R.; Strohbach, J.W.; Tommasi, R.A.; Aristoff, P.A.; Johnson, P.D.; Skulnick, H.I.; Dolak, L.A.; Seest, E.P.; Tomich, P.K.; Bohanon, M.J.; Horng, M.M.; Lynn, J.C.; Chong, K.T.; Hinshaw, R.R.; Watenpaugh, K.D.; Janakiraman, M.N.; Thaisrivongs, S.; Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem 1998, 41, 18, 3467. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17233 | 1-phenyl-3-hexanone | C12H16O | 详情 | 详情 | |
(II) | 11791 | methyl 3-oxobutanoate; Methyl acetoacetate | 105-45-3 | C5H8O3 | 详情 | 详情 |
(III) | 32879 | 4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C16H20O3 | 详情 | 详情 | |
(IV) | 12646 | 3-Nitrobenzaldehyde | 99-61-6 | C7H5NO3 | 详情 | 详情 |
(V) | 32880 | 3-[(Z)-(3-nitrophenyl)methylidene]-6-phenethyl-6-propyldihydro-2H-pyran-2,4-dione | C23H23NO5 | 详情 | 详情 | |
(VI) | 32881 | 4-hydroxy-3-[1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H29NO5 | 详情 | 详情 | |
(VII) | 32882 | 3-[1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H31NO3 | 详情 | 详情 | |
(VIII) | 17236 | (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H31NO3 | 详情 | 详情 | |
(IX) | 17237 | 5-(trifluoromethyl)-2-pyridinesulfonyl chloride | C6H3ClF3NO2S | 详情 | 详情 |
合成路线7
【1】 Wilken J. Nerenz F, Kanschik-Conndsen A. 2004. A process for the synthesis of 3-hydroxy3-(2-phenylethyl) hexanoic acid,useful as an intermediate for antiviral. US 2004110957(本专利属于Honey-well International, Inc.,USA) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 21159 | (3R)-3-hydroxy-3-phenethylhexanoic acid | C14H20O3 | 详情 | 详情 | |
(VII) | 66860 | (S)-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C16H20O3 | 详情 | 详情 | |
(I) | 17233 | 1-phenyl-3-hexanone | C12H16O | 详情 | 详情 | |
(II) | 16640 | Ethyl 2-bromoacetate; Ethyl bromoacetate | 105-36-2 | C4H7BrO2 | 详情 | 详情 |
(III) | 21156 | ethyl 3-hydroxy-3-phenethylhexanoate | C16H24O3 | 详情 | 详情 | |
(IV) | 13355 | 2-Amino-1-phenyl-1-propanol; (1S,2R)-(+)-Norephedrine | 37577-28-9 | C9H13NO | 详情 | 详情 |
(VI) | 66856 | (S)-ethyl 5-hydroxy-3-oxo-5-phenethyloctanoate | C18H26O4 | 详情 | 详情 | |
(IX) | 17236 | (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H31NO3 | 详情 | 详情 |
合成路线8
【1】 Trost BM, Andersen NG. 2002. Utilization of molybdenum-and palladium-catalyzed dynamic kinetic asymmetric transformations for the preparation of tertiary and quatemary stereogenic centers; a concise synthesis of tipranavir. J Am Chem Soc, 124 (48): 14320~14321 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IV) | 66865 | methyl 3-(3-nitrophenyl)pent-4-enoate | C12H13NO4 | 详情 | 详情 | |
(V) | 16524 | bromo(vinyl)magnesium | 1826-67-1 | C2H3BrMg | 详情 | 详情 |
(VII) | 66867 | 1-propyl-1-vinylcyclopropane | C8H14 | 详情 | 详情 | |
(IX) | 66869 | (E)-2-((4-methoxybenzyl)oxy)-2-styrylpentan-1-ol | C21H26O3 | 详情 | 详情 | |
(XII) | 66872 | (5S)-methyl 5-((4-methoxybenzyl)oxy)-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate | C34H39NO7 | 详情 | 详情 | |
(XIII) | 66873 | (5S)-methyl 5-hydroxy-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate | C26H31NO6 | 详情 | 详情 | |
(XIV) | 66874 | (S)-4-hydroxy-3-((R)-1-(3-nitrophenyl)allyl)-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H27NO5 | 详情 | 详情 | |
(XV) | 21168 | (6R)-4-hydroxy-3-[(1R)-1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H29NO5 | 详情 | 详情 | |
(I) | 66862 | 1-(3-nitrophenyl)prop-2-en-1-ol | C9H9NO3 | 详情 | 详情 | |
(II) | 66863 | tert-butyl (1-(3-nitrophenyl)allyl) carbonate | C14H17NO5 | 详情 | 详情 | |
(III) | 66864 | dimethyl 2-(1-(3-nitrophenyl)allyl)malonate | C14H15NO6 | 详情 | 详情 | |
(VI) | 66866 | 1-chloropentan-2-one | C5H9ClO | 详情 | 详情 | |
(VIII) | 66868 | 2-((4-methoxybenzyl)oxy)-2-vinylpentan-1-ol | C15H22O3 | 详情 | 详情 | |
(X) | 66870 | 2-((4-methoxybenzyl)oxy)-2-phenethylpentan-1-ol | C21H28O3 | 详情 | 详情 | |
(XI) | 66871 | 1-methoxy-4-(((3-phenethylhex-1-en-3-yl)oxy)methyl)benzene | C22H28O2 | 详情 | 详情 | |
(XVI) | 66879 | 2-((4-methoxybenzyl)oxy)-2-phenethylpentanal | C21H26O3 | 详情 | 详情 |
合成路线9
【1】 Judge TM, Phillips G, Moms JK, et aL. 1997. A symmetric syntheses and absolute stereochemistry of 5,6-dihydro-α-pyrones, a new class of potent HIV proteese inhibitors. J Am Chem Soc, 119 (15): 3627~3628 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 12173 | (4S)-4-Phenyl-1,3-oxazolan-2-one; (4S)-4-Phenyl-2-oxazolidinone; (S)-(+)-4-Phenyl-2-oxazolidinone | 99395-88-7 | C9H9NO2 | 详情 | 详情 |
(II) | 17227 | (4R)-3-[(E)-2-pentenoyl]-4-phenyl-1,3-oxazolan-2-one | C14H15NO3 | 详情 | 详情 | |
(III) | 17228 | N-(3-methylphenyl)-N,N-bis(trimethylsilyl)amine; trimethyl-N-(3-methylphenyl)-N-(trimethylsilyl)silanamine | C13H25NSi2 | 详情 | 详情 | |
(V) | 17231 | 2-methoxy-2-methyl-1,3-dioxolane; methyl 2-methyl-1,3-dioxolan-2-yl ether | C5H10O3 | 详情 | 详情 | |
(VI) | 17232 | (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione | C36H36N2O4 | 详情 | 详情 | |
(XI) | 66877 | 2-(1-(3-(dibenzylamino)phenyl)propyl)-5-hydroxy-1-(2-oxo-4-phenyloxazolidin-3-yl)-5-phenethyloctane-1,3-dione | C48H52N2O5 | 详情 | 详情 | |
(IV) | 17229 | (4R)-3-((3S)-3-[3-[bis(trimethylsilyl)amino]phenyl]pentanoyl)-4-phenyl-1,3-oxazolan-2-one | C26H38N2O3Si2 | 详情 | 详情 | |
(VII) | 10385 | 4-Heptanone; Dipropyl ketone | 123-19-3 | C7H14O | 详情 | 详情 |
(VIII) | 17233 | 1-phenyl-3-hexanone | C12H16O | 详情 | 详情 | |
(IX) | 66878 | 2-(1-(3-(dibenzylamino)phenyl)propyl)-5-hydroxy-1-(2-oxo-4-phenyloxazolidin-3-yl)-5-propyloctane-1,3-dione | C43H50N2O5 | 详情 | 详情 | |
(X) | 17234 | (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-1,3-octanedione | C48H52N2O5 | 详情 | 详情 | |
(XII) | 66875 | 3-(1-(3-(dibenzylamino)phenyl)propyl)-4-hydroxy-6,6-dipropyl-5,6-dihydro-2H-pyran-2-one | C34H41NO3 | 详情 | 详情 | |
(XIII) | 17235 | (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C39H43NO3 | 详情 | 详情 | |
(XIV) | 66876 | N-(3-(1-(4-hydroxy-2-oxo-6,6-dipropyl-5,6-dihydro-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide | C26H31F3N2O5S | 详情 | 详情 | |
(XVI) | 17238 | 1-phenyl-4-hexyn-3-one | C12H12O | 详情 | 详情 | |
(XVII) | 17239 | (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-6-octyne-1,3-dione | C48H48N2O5 | 详情 | 详情 | |
(XVIII) | 17240 | (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-(1-propynyl)-5,6-dihydro-2H-pyran-2-one | C39H39NO3 | 详情 | 详情 | |
(XIX) | 17236 | (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H31NO3 | 详情 | 详情 |